A study conducted with rats demonstrated that psilocybin, the psychoactive compound found in certain mushrooms, can prevent chemotherapy side effects without compromising the effectiveness of the anticancer treatment. The investigation, which culminated in promising results, suggests a potential clinical application of this substance in supporting cancer patients.
The researchers tested psilocybin in animal models subjected to chemotherapy treatment, observing a significant reduction in the adverse effects typically associated with this type of treatment, such as nausea, fatigue, and damage to healthy tissues.
The study represents a significant advance in oncology, offering a possible solution to improve the quality of life of patients during treatment. The results indicate that the substance can act as a protector without interfering with the treatment's ability to attack cancer cells.
The authors of the study highlight that more investigations are needed, including clinical trials in humans, to confirm these benefits and determine the appropriate dosages for therapeutic application.
